- TUL Degu and Liraglutide insulin compound preparation obtained clinical approval. Date： 2023-04-26 Browse：0
-
TUL Amoxicillin Capsules (specification: 0.5g) passed the consistency evaluation of generic drugs
Recently, TUL obtained the Notice of Approval of Supplementary Drug Application for Amoxicillin Capsules (specification: 0.5g) approved and issued by NMPA, which approved this product to pass the quality and efficacy consistency evaluation of generic drugs.
Date： 2023-04-26 Browse：151
- 2022 Annual Results Announcement Date： 2023-04-20 Browse：0
-
Zhuhai United Bio-Pharmaceutical Co., Ltd settled in Hengqin, and Mr. Tsoi Hoi Shan, Chairman of the Board of Directors, signed a cooperation agreement with the Executive Committee of Hengqin Guangdong Macao Deep Cooperation Zone
Date： 2023-04-26 Browse：194
In order to promote the high-quality development of the Hengqin Guangdong Macao Deep Cooperation Zone, the Executive Committee of the Cooperation Zone held a signing event with key projects such as Industrial and Commercial Bank of China, German Arentas, and ...
- TUL12101 eye drops, a class 1 new drug of TUL, was approved for clinical use Date： 2023-04-26 Browse：0
- 2020 Interim Results Announcement Date： 2020-09-17 Browse：0
-
TUL ranked No.21 in "top 100 pharmaceutical enterprises of China in 2019"
Date： 2020-09-17 Browse：1177
On August 30, 2020, the 37th national pharmaceutical industry information annual conference, sponsored by China Pharmaceutical Industry Information Center, was grandly opened in Zhuhai. The conference solemnly released the list of top 100 pharmaceutical enter...
-
TUL ranked No.18th in top 100 chemical pharmaceutical enterprises in China in 2019
Date： 2020-09-17 Browse：1124
The national pharmacy week, the annual meeting of China's top 100 pharmaceutical industry and the annual meeting of China's pharmaceutical Internet economy were held in Kunming yun'anHuidu International Conference Center from August 25 to 28, 2020. At the mee...
-
TUL was listed in the list of China's pharmaceutical health with the most investment potential in 2019-2020
Date： 2020-09-17 Browse：1135
On August 13, the list of "China's medical and health investment value ranking list in 2019-2020" was officially announced by xinkangjie. The enterprises participating in the selection are Chinese medical and health enterprises listed in A shares, Hong Kong s...
-
TUL won the "best IR team" of Sina Financial Jinqilin Hong Kong stock value list in 2020
Date： 2020-09-17 Browse：1170
On August 18, the results of the "2020 Jinqilin Hong Kong stock value list" sponsored by Sina Finance and economics were announced. With its positive capital market performance, The United Laboratories International Holdings Co., Ltd. (3933. HK) was awarded t...
-
TUL has been awarded as "Guangdong Province contract abiding and trustworthy enterprise" for 6 consecutive years
Date： 2020-09-17 Browse：1122
On June 1, Zhuhai United Laboratories Co., Ltd., Zhuhai United Laboratories Co., Ltd.(Zhongshan Branch), Zhuhai United Laboratories Trading Company Limited and Zhuhai United Laboratories (Wanbang) Co., Ltd. were awarded the title of "Guangdong Province contra...
-
Zhuhai United Laboratories Trading Company Limited was awarded "group member of the Second Council of Zhuhai People's Association for friendship with foreign countries"
Date： 2020-09-17 Browse：1443
On July 27, Zhuhai United Laboratories Trading Company Limited received the letter of appointment from Zhuhai People's Association for friendship with foreign countries and was officially appointed as a group member of the Second Council of them.The Zhuhai Pe...
-
TUL was selected into Hang Sengindex of "Shanghai, Shenzhen and Hong Kong innovative drug selection 50".
Date： 2020-09-17 Browse：1148
HSI announced earlier that the results of half year index review of Hang Seng Shanghai, Shenzhen and Hong Kong innovative drug selection 50 index as of April 30, 2020, including Livzon (01513), Genscript (01548), HANSOH Pharmaceutical (03692), TUL (03933), et...